Episode

Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio

Podcast: Few & Far Between: How Biotech Gets Built
Published: Apr 3, 2025
Duration seconds: 3305
Processing state: not_requested
Canonical source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-51-dan-oliver-ceo-and-founder-rejuvenate-bio
Audio: https://dts.podtrac.com/redirect.mp3/episodes.castos.com/6026d270a471b8-76273800/2006086/c1e-gk5k1amgx18a0989w-0v5rwqv0s25-pl6emi.mp3
JSON: /v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-51-dan-oliver-ceo-and-founder-rejuvenate-bio
Markdown: /podcast/few-far-between-how-biotech-gets-built-4067896/episode-51-dan-oliver-ceo-and-founder-rejuvenate-bio.md

Actions

POST https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-51-dan-oliver-ceo-and-founder-rejuvenate-bio/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-51-dan-oliver-ceo-and-founder-rejuvenate-bio.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

How do you turn back the epigenetic clock for humans and their animal companions? Host Chris O'Brien welcomes Dan Oliver, CEO and Founder of Rejuvenate Bio, to the podcast. Tune in as we take a deep dive into parallel clinical trials designed to address chronic, age-related diseases in people and their pets. Plus, we'll zoom in on the right corporate structure for biotech products and the benefits of brainstorming. Listen in to the latest episode of the Few & Far Between podcast today!